Dr Tash Pocovi
@PocoviTash
Followers
322
Following
307
Statuses
127
Post-Doctoral Research Fellow | Physiotherapy | Macquarie University
Sydney, New South Wales
Joined November 2019
The WalkBack Trial: An individualised and progressive walking and education program to prevent low back pain recurrence. Article now published @TheLancet - Link below:
17
95
163
The time difference was harsh, but the engagement and questions from the audience related to the WalkBack Trial were wondeful. Thanks for the invitation to present @EUROSPINESoc
Join the free Spine Tuesday Webinar on 21 Jan 2025 to explore evidence-based strategies for low back pain, including progressive walking, education, and spinal injection insights—register now: #LowBackPain #SpineWebinar
0
0
6
1
0
1
RT @anzmusc: Congratulations to the worthy runners-up of the Rapid-fire Research Showcase as well! @GemmaAltinger @Julia_ZhuShiyi @PocoviTa…
0
2
0
I always feel so fortunate to be surrounded (and supported) by these stellar researchers. The @Macquarie_Uni Spinal Pain Research Group contingent, mastering the art of selfies over in Adelaide for the @anzmusc ASM.
3
1
23
1
0
1
A big thank you to @anzmusc for hosting another terrific event! A wonderful opportunity to present, get up to speed with the latest research and network with some of the best in the biz. Looking forward to QLD 2025!
Thanks so much to everyone who attended the 2024 ANZMUSC ASM. We hope that you enjoyed it! #ANZMUSC2024 #MSKhealth 📸 @SimonDavidson88
0
0
12
0
0
2
RT @msk_health: "We have the pharmaceutical benefits scheme that funds medications, but we don't really have an equivalent system that fund…
0
6
0
What a privellage to be opening up the Sydney Spinal Symposium for 2024. Great opportunity to present progress in the treatment and prevention of low back pain with data from both the Restore & Walkback trials.
has started. Tash presenting her @TheLancet paper
0
0
20
RT @PeteOSullivanPT: New Systematic review of CFT Conclusion: The results show promise in the use of CFT as an intervention likely to effec…
0
45
0
@chris_neason @TheLancet Thanks for the kinds words, Chris. I was hoping that message would come across 🙏
0
0
0
@PainIMPACTNeuRA I hope is sparked some deep scientific discussions...or was atleast a decent read 😉
1
0
3
RT @Jess1E_zx: Final call 📢 We're getting close to 150 participants, but we still need more people to complete our survey! If you haven't…
0
11
0
@CGMMaher Thanks Chris. This only after a week! Hoping we eventually get to see some purple (policy) in that Altmetric donut 🍩 😄
0
0
6
@AsafKlaf @GregLehman @ArthriticChick So what would you pose as the perfectly designed trial and what would your ideal outcome/analysis be? We are happy for replication trials. Seeing as you have alot of interest on the topic and have been so critical of ours, are you looking to conduct one? 😊
1
0
2
@AsafKlaf @ArthriticChick Recurrence: needed to have atleast had one previous episode, but be recovered at the point of enrolment (atleast 7 consecutive days of pain no greater than 1/10 pain). Chronic: persistent pain, never recovering based on definition above.
0
0
3
1
0
2